rare diseases
Media
GSK Makes Strategic $1.15 Billion Move to Acquire IDRx, Strengthening Its Cancer Treatment Portfolio
British pharmaceutical giant GSK has announced its agreement to acquire Boston-based biotechnology firm IDRx for up to $1.15 billion, marking a significant expansion...
Billionairesworld's billionaires
Dona Bertarelli: A Life of Achievement, Adventure, and Philanthropy
Dona Bertarelli is a Swiss entrepreneur, philanthropist, and world-renowned sailor who has made a significant impact in both the business world and the...
Billionairesworld's billionaires
Zhao Ning: A Visionary Leader in Pharmaceutical Research
Zhao Ning, a pioneering figure in pharmaceutical research and cofounder of the globally acclaimed WuXi AppTec, left an enduring legacy in the healthcare...
